A robust Bayesian dose-finding design for phase I/II clinical trials (Q100711)

From MaRDI portal





scientific article
Language Label Description Also known as
default for all languages
No label defined
    English
    A robust Bayesian dose-finding design for phase I/II clinical trials
    scientific article

      Statements

      17
      0 references
      2
      0 references
      249-263
      0 references
      20 October 2015
      0 references
      0 references
      0 references

      Identifiers